These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

247 related items for PubMed ID: 9437726

  • 1. Effect of chronic administration of morphine, U-50, 488H and [D-Pen2, D-Pen5]enkephalin on the concentration of cGMP in brain regions and spinal cord of the mouse.
    Bhargava HN, Cao YJ.
    Peptides; 1997; 18(10):1629-34. PubMed ID: 9437726
    [Abstract] [Full Text] [Related]

  • 2. Effect of chronic administration of [D-Pen2, D-Pen5] enkephalin on the activity of nitric oxide synthase in brain regions and spinal cord of mice.
    Bhargava HN, Cao YJ.
    Peptides; 1998; 19(1):113-7. PubMed ID: 9437743
    [Abstract] [Full Text] [Related]

  • 3. Effect of 7-nitroindazole on tolerance to morphine, U-50,488H and [D-Pen2, D-Pen5] enkephalin in mice.
    Bhargava HN, Cao YJ, Zhao GM.
    Peptides; 1997; 18(6):797-800. PubMed ID: 9285927
    [Abstract] [Full Text] [Related]

  • 4. Roles of mu, delta and kappa opioid receptors in spinal and supraspinal mediation of gastrointestinal transit effects and hot-plate analgesia in the mouse.
    Porreca F, Mosberg HI, Hurst R, Hruby VJ, Burks TF.
    J Pharmacol Exp Ther; 1984 Aug; 230(2):341-8. PubMed ID: 6086883
    [Abstract] [Full Text] [Related]

  • 5. Effect of chronic administration of U-50,488H on tolerance to its pharmacological actions and on multiple opioid receptors in rat brain regions and spinal cord.
    Bhargava HN, Gulati A, Ramarao P.
    J Pharmacol Exp Ther; 1989 Oct; 251(1):21-6. PubMed ID: 2552075
    [Abstract] [Full Text] [Related]

  • 6. Interactions of cocaine with morphine, U-50,488H and [D-Pen2, D-Pen5]enkaphalin.
    Bhargava HN, Cao YJ.
    Peptides; 1998 Oct; 19(3):563-8. PubMed ID: 9533646
    [Abstract] [Full Text] [Related]

  • 7. Streptozotocin-induced diabetes selectively alters the potency of analgesia produced by mu-opioid agonists, but not by delta- and kappa-opioid agonists.
    Kamei J, Ohhashi Y, Aoki T, Kawasima N, Kasuya Y.
    Brain Res; 1992 Feb 07; 571(2):199-203. PubMed ID: 1319265
    [Abstract] [Full Text] [Related]

  • 8. Multiplicative interaction between intrathecally and intracerebroventricularly administered mu opioid agonists but limited interactions between delta and kappa agonists for antinociception in mice.
    Roerig SC, Fujimoto JM.
    J Pharmacol Exp Ther; 1989 Jun 07; 249(3):762-8. PubMed ID: 2567350
    [Abstract] [Full Text] [Related]

  • 9. Direct evidence for the up-regulation of spinal micro-opioid receptor function after repeated stimulation of kappa-opioid receptors in the mouse.
    Narita M, Khotib J, Mizoguchi H, Suzuki M, Ozaki S, Yajima Y, Tseng LF, Suzuki T.
    Eur J Neurosci; 2003 Nov 07; 18(9):2498-504. PubMed ID: 14622150
    [Abstract] [Full Text] [Related]

  • 10. Heterologous mu-opioid receptor adaptation by repeated stimulation of kappa-opioid receptor: up-regulation of G-protein activation and antinociception.
    Narita M, Khotib J, Suzuki M, Ozaki S, Yajima Y, Suzuki T.
    J Neurochem; 2003 Jun 07; 85(5):1171-9. PubMed ID: 12753076
    [Abstract] [Full Text] [Related]

  • 11. Regional, developmental, and cell cycle-dependent differences in mu, delta, and kappa-opioid receptor expression among cultured mouse astrocytes.
    Stiene-Martin A, Zhou R, Hauser KF.
    Glia; 1998 Mar 07; 22(3):249-59. PubMed ID: 9482211
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Absence of G-protein activation by mu-opioid receptor agonists in the spinal cord of mu-opioid receptor knockout mice.
    Narita M, Mizoguchi H, Narita M, Sora I, Uhl GR, Tseng LF.
    Br J Pharmacol; 1999 Jan 07; 126(2):451-6. PubMed ID: 10077238
    [Abstract] [Full Text] [Related]

  • 15. Contrasting actions of intrathecal U50,488H, morphine, or [D-Pen2, D-Pen5] enkephalin or intravenous U50,488H on the visceromotor response to colorectal distension in the rat.
    Harada Y, Nishioka K, Kitahata LM, Nakatani K, Collins JG.
    Anesthesiology; 1995 Aug 07; 83(2):336-43. PubMed ID: 7631956
    [Abstract] [Full Text] [Related]

  • 16. Effects of morphine-3-glucuronide on the antinociceptive activity of peptide and nonpeptide opioid receptor agonists in mice.
    Bian JT, Bhargava HN.
    Peptides; 1996 Aug 07; 17(8):1415-9. PubMed ID: 8971939
    [Abstract] [Full Text] [Related]

  • 17. Effects of differential modulation of mu-, delta- and kappa-opioid systems on bicuculline-induced convulsions in the mouse.
    Yajima Y, Narita M, Takahashi-Nakano Y, Misawa M, Nagase H, Mizoguchi H, Tseng LF, Suzuki T.
    Brain Res; 2000 Apr 17; 862(1-2):120-6. PubMed ID: 10799676
    [Abstract] [Full Text] [Related]

  • 18. Role of nitric oxide/cyclic GMP in i.c.v. administered beta-endorphin- and (+)-cis-dioxolane-induced antinociception in the mouse.
    Xu JY, Tseng LF.
    Eur J Pharmacol; 1994 Sep 12; 262(3):223-31. PubMed ID: 7813587
    [Abstract] [Full Text] [Related]

  • 19. Differential effects of two kappa-opiate agonists, U-50,488H and U-69,593, on the binding of 3H-(3-MeHis2) thyrotropin-releasing hormone to rat spinal cord and amygdala membranes.
    Rahmani NH, Gulati A, Bhargava HN.
    Pharmacology; 1991 Sep 12; 43(3):156-62. PubMed ID: 1663623
    [Abstract] [Full Text] [Related]

  • 20. Effect of multiple injections of U-50, 488H, a kappa-opioid receptor agonist, on the activity of nitric oxide synthase in brain regions and spinal cord of mice.
    Bhargava HN, Kumar S.
    Gen Pharmacol; 1997 Sep 12; 29(3):397-9. PubMed ID: 9378246
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.